Bolt Biotherapeutics Inc

XNAS:BOLT

4.30

-0.05 (-1.15%)

7:24:24 PM EDT: $4.39 +0.09 (+2.02%)

Market Cap (Intraday)	8.25M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.67 Million
Adjusted EPS	-$6.11

See more estimates

10-Day MA	$4.57
50-Day MA	$5.52
200-Day MA	$5.57

See more pivots

Bolt Biotherapeutics Inc Stock, XNAS:BOLT

900 Chesapeake Drive, Redwood City, California 94063

United States of America

Phone: +1.650.665.9295

Number of Employees: 100

http://www.boltbio.com

Description

Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. The company was founded by Edgar G. Engleman on January 22, 2015 and is headquartered in Redwood City, CA.